Steve Elms - Feb 19, 2025 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role: Director
Signature: /s/ Steve Elms, by Michael A. Goldstein as Attorney-in-fact
Stock symbol: ADMA
Transactions as of: Feb 19, 2025
Transactions value $: $0
Form type: 4
Date filed: 2/21/2025, 09:05 PM
Previous filing: Feb 14, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ADMA	Common Stock	Award	$0	+10.9K	+14.24%	$0.00	87.3K	Feb 19, 2025	Direct	F1, F2
holding	ADMA	Common Stock						2.12M	Feb 19, 2025	See footnote	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ADMA	Stock Option (Right to Buy)	Award	$0	+16.3K		$0.00	16.3K	Feb 19, 2025	Common Stock	16.3K	$16.07	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.
F2	Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 RSUs granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (iii) 64,421 shares of common stock owned by the reporting person.
F3	These shares are owned by Aisling Capital II LP ("Aisling"), which is a fund that was established in 2007 with a 10-year life. Mr. Elms is Aisling's designee for nomination to the Board. As a Managing Member of Aisling Capital Partners, LLC ("Aisling Partners"), a control person of Aisling, and as a member of the investment committee of Aisling Capital Partners, LP ("Aisling GP"), Mr. Elms may be deemed to be the beneficial owner of shares of common stock owned of record by Aisling. Mr. Elms disclaims beneficial ownership of Aisling's investment in the Company and Aisling Partners' ownership of the Company's options, except to the extent of his pecuniary interest therein.
F4	The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.